ImmunoGen
IMGN
$31.23
Share price
0.00%
Change (1 day)
636.56%
Change (1 year)
Categories
ImmunoGen (IMGN) - Total debt
Total debt on the balance sheet as of September 2023 : $84.33 M
According to ImmunoGen 's latest financial reports the company's total debt is $84.33 M. A company’s total debt is the sum of all current and non-current debts.
ImmunoGen - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $15.24 M | -18.83% |
| 2021-12-31 | $18.78 M | -21.39% |
| 2020-12-31 | $23.89 M | -11.01% |
| 2019-12-31 | $26.84 M | 1200.73% |
| 2018-12-31 | $2.06 M | 0.68% |
| 2017-12-31 | $2.05 M | |
| 2016-06-30 | $96.62 M | |
| 2001-06-30 | $0 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | 34,682.40% | 🇺🇸 USA |
 Novartis NVS | $26.34 B | 31,143.92% | 🇨🇭 Switzerland |
 Pfizer PFE | $70.84 B | 83,909.25% | 🇺🇸 USA |
 Eli Lilly LLY | $25.22 B | 29,812.61% | 🇺🇸 USA |
 Amgen AMGN | $64.61 B | 76,519.23% | 🇺🇸 USA |
 Sanofi SNY | $20.36 B | 24,051.67% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $41.46 B | 49,068.74% | 🇺🇸 USA |
 Seagen
SGEN | $0.11 B | 34.57% | 🇺🇸 USA |